Healthcare - Press Releases

Date	Title	Company
24-Feb-2022	Skymount Medical Receives UK MHRA Approval to Test New Treatment in Patients with Mild to Moderate COVID-19	Skymount Medical
24-Feb-2022	Trial shows Koa Health’s Foundations app can improve measures of mental wellbeing in only four weeks	Koa Health
24-Feb-2022	Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine	Sanofi
24-Feb-2022	Dante Labs selected as Genetic Tests provider for Abu Dhabi Executive Office Employee’s Wellbeing Week	Dante Labs
24-Feb-2022	ConserV Bioscience pan-coronavirus project has been awarded UK Aid funding by the UK Vaccine Network, delivered by Innovate UK	ConserV Bioscience
24-Feb-2022	‘Ending free Covid testing on April Fool’s Day is ironically appropriate,’ says expert	London Medical Laboratory
23-Feb-2022	New Phase 2b Data Show the Majority of Adults with Moderately to Severely Active Ulcerative Colitis Achieved Clinical Response with TREMFYA®▼ (guselkumab) at 12 Weeks	Janssen
23-Feb-2022	Results of Novel Clinical Study Show Adults with Moderately to Severely Active Ulcerative Colitis Achieved Higher Rates of Clinical Response, Clinical Remission, and Endoscopic Improvement at 12 Weeks with Guselkumab▼ and Golimumab Combination Therapy Versus Either Monotherapy Alone	Janssen
23-Feb-2022	The Majority of Adults with Moderately to Severely Active Crohn’s Disease in a Phase 2 Study Achieved Clinical Remission and Corticosteroid-Free Remission Through 48 Weeks with TREMFYA®▼ (guselkumab)	Janssen
23-Feb-2022	Innovative solutions to the exploitation of health data in the global South	Warwick University
23-Feb-2022	CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021	Aoxin Q&M Dental Group Ltd
23-Feb-2022	miDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study	miDiagnostics
23-Feb-2022	NHS gene testing does not detect half of people at cancer risk	The Institute of Cancer Research, London
23-Feb-2022	Lockdown doubled risk of mental distress on UK adolescents with previous mental health difficulties	UK Millennium Cohort Study
22-Feb-2022	Europe’s Only Parallel Trade Conference returns for its 16th Year	SMi Group
22-Feb-2022	MBMV invests in international bio-tech startup Arcensus GmbH	Arcensus GmbH
21-Feb-2022	Paul Archer promoted to Chief Commercial Strategy Officer, Envision Pharma Group	Envision Pharma Group
18-Feb-2022	QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS® PLATFORM	Quotient Sciences
16-Feb-2022	Pain Therapeutics - Keynote Opening Addresses From The Pain Society And Eptiva Therapeutics	SMi Group
15-Feb-2022	FIRST CPD STANDARDS FOR HEALTHCARE COMMUNICATIONS PROFESSIONALS	Healthcare Communications Association